| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7df267c0e21d6b0ad2a3490807c38477
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_716e9a2606ffd4ba1a2a3917e4a402fd |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 |
| filingDate |
2020-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90c78c3e19eabeef44e6aa1c2a8464a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5a6ca3513ebf2b0681e88cca13b7f1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5aa6a9f1e6d4b3e559d6edb8353cbf1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b7b3c3db1957bf76eb0cecac539f5e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d4882b890c9e8d9a192372d693f7772 |
| publicationDate |
2021-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021025018-A1 |
| titleOfInvention |
Pharmaceutical composition for therapy and/or prophylaxis of colorectal cancer |
| abstract |
The present disclosure provides a pharmaceutical composition or method for therapy and/or prophylaxis of cancer, or a screening method for screening for a substance or a factor for therapy and/or prophylaxis of cancer.　The present disclosure provides a pharmaceutical composition that is for therapy and/or prophylaxis of cancer accompanied by chronic inflammation, and that contains an NFKBIZ inhibitor. Examples of the NFKBIZ inhibitor include substances that inhibit the expression and/or function of NFKBIZ. The cancer accompanied by chronic inflammation is preferably an enterocolitis-associated cancer observed in ulcerative colitis. |
| priorityDate |
2019-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |